Shipment of Human Islets for Transplantation

The use of regional human islet cell processing centers (ICPC) supporting distant clinical islet transplantation programs (CITP) has proven successful in recent clinical trials. Standardization of islet shipping protocols is needed to preserve cell product identity, quantity, quality and sterility, and to meet criteria for transplantation. We evaluated the use of gas‐permeable bags for human islet preparation shipment from a single ICPC to two remote CITPs. Product release tests (counts, purity, viability, sterility and potency) were performed at both centers using identical protocols to determine adequacy for transplantation. Thirty‐five islet preparations were shipped either immediately after isolation (n = 20) or following culture (n = 15). Islet recovery rate after shipment was higher in cultured preparations, when compared to those not cultured (91.2 ± 4.9% vs. 72.9 ± 4.7%, respectively; p < 0.05), though the overall recovery rate based on isolation and pre‐transplant counts was comparable (72.9 ± 4.7% vs. 70.4 ± 3.5%, respectively; p = N.S.). All preparations met product release criteria for transplantation. Additional experiments showed that gas‐permeable bags led to improved recovery and potency, when compared to 50‐mL conical tubes or to non‐gas‐permeable bags for shipment. Collectively, our data demonstrate that the use of gas‐permeable bags is efficient for clinical‐grade and should be preferred also for the shipment of research‐grade islet preparations.

[1]  S. Messinger,et al.  Improved Human Islet Isolation Using Nicotinamide , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  P. Haaland,et al.  The Use of the BD Oxygen Biosensor System to Assess Isolated Human Islets of Langerhans: Oxygen Consumption as a Potential Measure of Islet Potency , 2006, Cell transplantation.

[3]  C. Ricordi,et al.  Islet Transplantation in Type 1 Diabetes Mellitus Using Cultured Islets and Steroid‐Free Immunosuppression: Miami Experience , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  James D. Johnson,et al.  Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. , 2005, Archives of surgery.

[5]  Shari Messinger,et al.  A Novel Method for the Assessment of Cellular Composition and Beta‐Cell Viability in Human Islet Preparations , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  A. Shapiro,et al.  Five-year follow-up after clinical islet transplantation. , 2005, Diabetes.

[7]  E. Bonifacio,et al.  Islet isolation for allotransplantation: variables associated with successful islet yield and graft function , 2005, Diabetologia.

[8]  B. Hering,et al.  Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. , 2005, JAMA.

[9]  C. Ricordi,et al.  Rescue Purification Maximizes the Use of Human Islet Preparations for Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  Jonathan R T Lakey,et al.  Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. , 2004, Diabetes.

[11]  O. Korsgren,et al.  Refinement of the Automated Method for Human Islet Isolation and Presentation of a Closed System for In Vitro Islet Culture , 2004, Transplantation.

[12]  T. Berney,et al.  LOGISTICS AND TRANSPLANT COORDINATION ACTIVITY IN THE GRAGIL SWISS-FRENCH MULTICENTER NETWORK OF ISLET TRANSPLANTATION , 2004, Transplantation.

[13]  A. Shapiro,et al.  Influence of Pancreas Preservation on Human Islet Isolation Outcomes: Impact of the Two-Layer Method , 2004, Transplantation.

[14]  C. Ricordi,et al.  The Use of Multiparametric Monitoring during Islet Cell Isolation and Culture: A Potential Tool for In-Process Corrections of Critical Physiological Factors , 2004, Cell transplantation.

[15]  J. Markmann,et al.  Assessment of human pancreatic islets after long distance transportation. , 2004, Transplantation proceedings.

[16]  T. Berney,et al.  INFLUENCE OF ISLET TRANSPORTATION ON PANCREATIC ISLET ALLOTRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS WITHIN THE SWISS-FRENCH GRAGIL NETWORK , 2004, Transplantation.

[17]  J. Bluestone,et al.  Transplantation of Cultured Islets from Two‐Layer Preserved Pancreases in Type 1 Diabetes with Anti‐CD3 Antibody , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  F. Brunicardi,et al.  Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center , 2004, Transplantation.

[19]  C. Ricordi.  Islet transplantation: a brave new world. , 2003, Diabetes.

[20]  B. Hering,et al.  Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation1 , 2003, Transplantation.

[21]  B. Wolf,et al.  Insulin Independence Following Isolated Islet Transplantation and Single Islet Infusions , 2003, Annals of surgery.

[22]  C. Ricordi,et al.  Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution , 2003, Transplantation.

[23]  J. Lakey,et al.  Evaluation of Pefabloc as a serine protease inhibitor during human-islet isolation , 2003, Transplantation.

[24]  J. Reems,et al.  Improved Islet Yields From Macaca Nemestrina and Marginal Human Pancreata After Two‐Layer Method Preservation and Endogenous Trypsin Inhibition , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  C. Ricordi,et al.  Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center , 2002, Transplantation.

[26]  C. Ricordi,et al.  Islet Cell Transplantation: In Vivo and in Vitro Functional Assessment of Nonhuman Primate Pancreatic Islets , 2000, Cell transplantation.

[27]  J. Rabkin,et al.  Distant processing of pancreas islets for autotransplantation following total pancreatectomy. , 1999, American journal of surgery.

[28]  C. Ricordi,et al.  Improved Human Islet Isolation Using a New Enzyme Blend, Liberase , 1997, Diabetes.

[29]  P. Stock,et al.  Clinical islet transplantation experience of the University of California Islet Transplant Consortium. , 1995, Surgery.

[30]  D. Dunn,et al.  Autologous Islet Transplantation to Prevent Diabetes After Pancreatic Resection , 1995, Annals of surgery.

[31]  F. Brunicardi,et al.  Reduction in immunogenicity of human islets by 24 degrees C culture. , 1994, Transplantation proceedings.

[32]  M. Andreeff,et al.  Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors. , 1992, Experimental hematology.

[33]  Peter J. Morris,et al.  Islet isolation assessment in man and large animals , 1990, Acta diabetologia latina.

[34]  R. James,et al.  A microfluorometric viability assay for isolated human and rat islets of Langerhans. , 1989, Diabetes research.

[35]  T. Tanaka,et al.  Pancreatic secretory trypsin inhibitor as a marker for early detection of rejection in canine pancreas allotransplantation. , 1988, Transplantation.

[36]  Y. Kuroda,et al.  A new, simple method for cold storage of the pancreas using perfluorochemical. , 1988, Transplantation.

[37]  Camillo Ricordi,et al.  Automated Method for Isolation of Human Pancreatic Islets , 1988, Diabetes.

[38]  P. Lacy,et al.  Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Lacy,et al.  Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. , 1979, Science.

[40]  T. Strom,et al.  ISLET TRANSPLANTATION : ADVANCES AND IMMUNOLOGICAL CHALLENGES , 2004 .

[41]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[42]  R. Alejandro,et al.  A simple method of staining fresh and cultured islets. , 1988, Transplantation.